基于非线性混合效应模型和群体模型选择的单时间点肾脏剂量学在[177Lu]Lu-PSMA-617治疗中的应用
本研究利用63例转移性去势抵抗性前列腺癌患者的SPECT/CT数据,评估单时间点肾脏剂量学结合非线性混合效应模型和群体模型选择的准确性。结果显示注射后约2天(42.6±1.0小时)的单次SPECT/CT测量计算肾脏吸收剂量平均相对偏差为-4.4%±9.4%,中位相对偏差-0.7%,该方法优于Hänscheid和Madsen方法。
要点
- 注射后2天单次SPECT/CT测量结合NLME和PBMS可准确计算肾脏吸收剂量
- 时间点3(42.6±1.0小时)的平均相对偏差为-4.4%±9.4%,中位相对偏差-0.7%
- PBMS NLME方法在所有研究时间点均优于Hänscheid和Madsen方法
核心结论
- 结果表明注射后2天单次SPECT/CT测量可能用于计算准确的肾脏吸收剂量,采用NLME方法和PBMS。
研究设计与样本
- 研究纳入63例转移性去势抵抗性前列腺癌患者,获取[177Lu]Lu-PSMA-617在肾脏的生物动力学数据,时间点1(1.8±0.8小时)、2(18.7±0.9小时)、3(42.6±1.0小时)、4(66.3±0.9小时)、5(160.3±24.2小时),使用SPECT/CT。
- 从1至5指数函数的不同参数化推导出13个函数,在NLME框架中拟合全部时间点数据,并使用PBMS NLME方法通过拟合优度检验和Akaike权重选择最佳函数。
- 单时间点剂量学中,将特定患者的单时间点数据与其他所有患者的全部时间点数据同时拟合,计算单时间点时间积分活度和吸收剂量,并与Hänscheid和Madsen方法比较。
主要发现
- 函数[公式见原文]被选为最佳拟合全部时间点函数,Akaike权重为100%。
- 单时间点剂量学中,时间点3(42.6±1.0小时)的SPECT/CT测量显示平均相对偏差为-4.4%±9.4%,中位相对偏差为-0.7%。
- 时间点3的均方根误差值在5个时间点中最低,时间点1-5的吸收剂量相对偏差的均方根误差分别为23%、16%、10%、20%和53%。
- 使用PBMS NLME方法的单时间点剂量学在所有研究时间点均优于Hänscheid和Madsen方法。
关键数值与推荐
- 最佳拟合全部时间点函数为[公式见原文],Akaike权重100%。
- 时间点3(42.6±1.0小时)平均相对偏差-4.4%±9.4%,中位相对偏差-0.7%。
- 时间点1-5的吸收剂量相对偏差均方根误差分别为23%、16%、10%、20%、53%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this study was to investigate the accuracy of single-time-point (STP) renal dosimetry imaging using SPECT/CT data, a nonlinear mixed-effects (NLME) model, and a population-based model selection (PBMS) in a large population for 177Lu-labeled prostate-specific membrane antigen therapy. Methods: Biokinetic data (mean ± SD) of [177Lu]Lu-PSMA-617 in kidneys at time points 1 (1.8 ± 0.8 h), 2 (18.7 ± 0.9 h), 3 (42.6 ± 1.0 h), 4 (66.3 ± 0.9 h), and 5 (160.3 ± 24.2 h) after injection were obtained from 63 patients with metastatic castration-resistant prostate cancer using SPECT/CT. Thirteen functions were derived from various parameterizations of 1- to 5-exponential functions. The function's parameters were fitted in the NLME framework to the all-time-point (ATP) data. The PBMS NLME method was performed using the goodness-of-fit test and Akaike weight to select the best function fitting the data. The best function from ATP fitting was used to calculate the reference time-integrated activity and absorbed doses. In STP dosimetry, the parameters of a particular patient with STP data were fitted simultaneously to the STP data at different time points of that patient with ATP data of all other patients. The parameters from STP fitting were used to calculate the STP time-integrated activity and absorbed doses. Relative deviations (RDs) and root-mean-square errors (RMSEs) were used to analyze the accuracy of the calculated STP absorbed dose compared with the reference absorbed dose obtained from the best-fit ATP function. The performance of STP dosimetry using PBMS NLME modeling was compared with the Hänscheid and Madsen methods. Results: The function [Formula: see text] was selected as the best-fit ATP function, with an Akaike weight of 100%. For STP dosimetry, the STP measurement by SPECT/CT at time point 3 (42.6 ± 1.0 h) showed a relatively low mean RD of -4.4% ± 9.4% and median RD of -0.7%. Time point 3 had the lowest RMSE value compared with those at the other 4 time points. The RMSEs of the absorbed dose RDs for time points 1-5 were 23%, 16%, 10%, 20%, and 53%, respectively. The STP dosimetry using the PBMS NLME method outperformed the Hänscheid and Madsen methods for all investigated time points. Conclusion: Our results show that a single measurement of SPECT/CT at 2 d after injection might be used to calculate accurate kidney-absorbed doses using the NLME method and PBMS.
引用
- Hardiansyah D, Yousefzadeh-Nowshahr E, Kind F, et al. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [177Lu]Lu-PSMA-617 Therapy. J Nucl Med. 2024. PMID: 38423787. doi:10.2967/jnumed.123.266268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。